Early Notification and Brand Change Bortezomib Injection 3.5 mg & 1 mg for ECP
As advised via PHARMAC proposal of 22 October 2019 and the notification of PHARMAC decision of 5 December 2019 there is to be a change in the listing and future sole supply of bortezomib injections.
New listing from 1 March 2020
Bortezomib – Dr Reddy’s Inj 3.5 mg vial Pharmacode TBA Schedule price $105.00
Bortezomib – Baxter Inj 1 mg for ECP Pharmacode TBA Schedule price $31.20
Incumbent brand Velcade
Velcade Inj 3.5 mg vial Pharmacode 2275848 Schedule price $1892.50
Velcade – Baxter Inj 1 mg for ECP Pharmacode 2383667 Schedule price $594.77
HSS (Hospital Supply Status) & CSS (Community Supply Status) commences 1 August 2020.
PCT only – Specialist therefore only able to be dispensed and claimed by DHB Hospital Pharmacies.
Special Authority to be amended.
As of the date of this notification ProPharma / PWR cannot accept Velcade Inj for credit under any circumstances.
We would recommend you consider changing as soon as practical. This product is purchased on a PROCURE basis only.
Together we can make this a seamless and painless transition.
We thank you in anticipation of your ongoing support.